Open Actively Recruiting

Clinical Trials in Organ Transplantation Extension Study

About

Brief Summary

The purpose of the study is to continue to follow subjects who were enrolled in the CTOT-20 CLAD Phenotypes study. Subjects will provide clinical data and complete quality of life questionnaires that will be used to determine the clinical factors associated with the development of Chronic Lung Allograft Dysfunction (CLAD) after lung transplant.

Study Type
observational_patient_registry

Eligibility

Gender
All
Healthy Volunteers
No
Minimum Age
18 Years
Maximum Age
N/A

Inclusion Criteria:

  • Current CTOT-20 participants

Exclusion Criteria:

  • Non-CTOT-20 participants
  • Withdrawn CTOT-20 participants

Join this Trial

Contact our clinical trial navigators for opportunities that may be suitable for you
Study Stats
Protocol No.
19-001878
Category
Pulmonary Disease
Principal Investigator
Contact
John Belperio
Location
  • UCLA Westwood
For Providers
NCT No.
NCT04126746
For detailed technical eligibility, visit ClinicalTrials.gov.